Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 323-329

  Westenskow, Peter D ^a   Kurihara, Toshihide ^a   Friedlander, Martin ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

AMD; Cell based therapy; RPE; Stem cell biology; Translational medicine

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ARTICLE; ATROPHY; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; EMBRYONIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDUSTRIALIZATION; NONHUMAN; NUCLEAR REPROGRAMMING; PATIENT SAFETY; PHOTORECEPTOR; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETINA PIGMENT CELL; SKIN CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT; VISION; VISUAL IMPAIRMENT; CELL TRANSPLANTATION; CYTOLOGY; METHODOLOGY; PATHOLOGY; PIGMENT EPITHELIUM; RETINA MACULA DEGENERATION; REVIEW; TRANSLATIONAL RESEARCH;

ANIMALIA;

CELL TRANSPLANTATION; EMBRYONIC STEM CELLS; HUMANS; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84904792198     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_41     Document Type: Article

References (43)

1. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85(3):845-881
2. Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS et al (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122(4):477-485
3. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP et al (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82(11):844-851
4. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT et al (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122(4):564-572
5. Bird AC (2010) Therapeutic targets in age-related macular disease. J Clin Invest 120(9):3033-3041
6. Algvere PV, Gouras P, Dafgard Kopp E (1999) Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 9(3):217-230
7. Cahill MT, Freedman SF, Toth CA (2003) Macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch Ophthalmol 121(1):132-133
8. Joussen AM, Joeres S, Fawzy N, Heussen FM, Llacer H, van Meurs JC et al (2007) Autologous translocation of the choroid and retinal pigment epithelium in patients with geographic atrophy. Ophthalmology 114(3):551-560
9. Zhang X, Bok D (1998) Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci 39(6):1021-1027
10. Marc R (2005) Retinal remodeling. J Vis 5(12):5
11. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861-872
12. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920
13. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K et al (2008) Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321(5889):699-702
14. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD et al (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144(3):439-452
15. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E et al (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471(7336):58-62
16. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R et al (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8(1):106-118
17. Markoulaki S, Hanna J, Beard C, Carey BW, Cheng AW, Lengner CJ et al (2009) Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol 27(2):169-171
18. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT et al (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7(4):521-531
19. Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, Baldwin KK et al (2011) Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9(4):366-373
20. Zhao T, Zhang Z-N, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474(7350):212-215
21. Idelson M, Alper R, Obolensky A, Ben-Shushan E, Hemo I, Yachimovich-Cohen N et al (2009) Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 5(4):396-408
22. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, Lanza R (2004) Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6(3):217-245
23. Lund RD, Wang S, Klimanskaya I, Holmes T, Ramos-Kelsey R, Lu B et al (2006) Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8(3):189-199
24. Meyer JS, Shearer RL, Capowski EE, Wright LS, Wallace KA, McMillan EL et al (2009) Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci 106(39):16698-16703
25. Vugler A, Carr AJ, Lawrence J, Chen LL, Burrell K, Wright A et al (2008) Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 214(2):347-361
26. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, Johnson LV et al (2009) Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27(10):2427-2434
27. Carr AJ, Vugler AA, Hikita ST, Lawrence JM, Gias C, Chen LL et al (2009) Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 4(12):e8152
28. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H et al (2009) Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 458(3):126-131
29. Krohne T, Westenskow P, Kurihara T, Friedlander D, Lehmann M, Dorsey A et al (2012) Generation of retinal pigment epithelial cells from small molecules and OCT4-reprogrammed human induced pluripotent stem cells. Stem Cells Trans Med 1(2):96-109
30. Osakada F, Jin ZB, Hirami Y, Ikeda H, Danjyo T, Watanabe K et al (2009) In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 122(Pt 17):3169-3179
31. Mircheff AK, Miller SS, Farber DB, Bradley ME, O'Day WT, Bok D (1990) Isolation and provisional identification of plasma membrane populations from cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 31(5):863-878
32. Kokkinaki M, Sahibzada N Golestaneh N (2011) Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 29(5):825-835
33. Carr AJ, Vugler A, Lawrence J, Chen LL, Ahmado A, Chen FK et al (2009) Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 15:283-295
34. Westenskow PD, Moreno SK, Krohne TU, Kurihara T, Zhu S, Zhang ZN et al (2012) Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cells. Invest Ophthalmol Vis Sci 53(10):6282-6290
35. Schwartz SD, Hubschman J-P, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713-720
36. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L et al (2009) Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 27(9):2126-2135
37. Sheridan C, Williams R, Grierson I (2004) Basement membranes and artificial substrates in cell transplantation. Graefes Arch Clin Exp Ophthalmol 242(1):68-75
38. Williams RL, Krishna Y, Dixon S, Haridas A, Grierson I, Sheridan C (2005) Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J Mater Sci Mater Med 16(12):1087-1092
39. Okita K, Ichisaka T, Yamanaka S. 2007 Generation of germline-competent induced pluripotent stem cells. Nature 448(7151):313-317
40. Karamehic J, Ridic O, Jukic T, Ridic G, Slipicevic O, Coric J et al (2011) Financial aspects of the immunosuppressive therapy. Med Arh 65(6):357-362
41. Tezel TH, Del Priore LV, Berger AS, Kaplan HJ (2007) Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol 143(4):584-595
42. Eiraku M, Takata N, Ishibashi H, Kawada M, Sakakura E, Okuda S et al (2011) Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472(7341):51-56
43. Nakano T, Ando S, Takata N, Kawada M, Muguruma K, Sekiguchi K et al (2012) Selfformation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 10(6):771-785